Abeona Therapeutics Inc (ABEO)
4.31
-0.14
(-3.15%)
USD |
NASDAQ |
May 21, 16:00
4.31
0.00 (0.00%)
After-Hours: 20:00
Abeona Therapeutics Enterprise Value: 133.25M for May 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 21, 2024 | 133.25M |
| May 20, 2024 | 139.01M |
| May 17, 2024 | 136.95M |
| May 16, 2024 | 145.19M |
| May 15, 2024 | 149.72M |
| May 14, 2024 | 128.72M |
| May 13, 2024 | 132.83M |
| May 10, 2024 | 128.72M |
| May 09, 2024 | 137.51M |
| May 08, 2024 | 135.47M |
| May 07, 2024 | 142.01M |
| May 06, 2024 | 92.27M |
| May 03, 2024 | 87.13M |
| May 02, 2024 | 67.87M |
| May 01, 2024 | 63.46M |
| April 30, 2024 | 69.79M |
| April 29, 2024 | 50.51M |
| April 26, 2024 | 45.55M |
| April 25, 2024 | 43.62M |
| April 24, 2024 | 43.07M |
| April 23, 2024 | 49.68M |
| April 22, 2024 | 158.51M |
| April 19, 2024 | 164.29M |
| April 18, 2024 | 163.19M |
| April 17, 2024 | 174.21M |
| Date | Value |
|---|---|
| April 16, 2024 | 169.53M |
| April 15, 2024 | 166.22M |
| April 12, 2024 | 163.74M |
| April 11, 2024 | 170.35M |
| April 10, 2024 | 158.51M |
| April 09, 2024 | 160.71M |
| April 08, 2024 | 162.92M |
| April 05, 2024 | 160.71M |
| April 04, 2024 | 167.87M |
| April 03, 2024 | 177.52M |
| April 02, 2024 | 161.81M |
| April 01, 2024 | 168.43M |
| March 28, 2024 | 146.10M |
| March 27, 2024 | 148.56M |
| March 26, 2024 | 149.11M |
| March 25, 2024 | 150.20M |
| March 22, 2024 | 155.95M |
| March 21, 2024 | 153.76M |
| March 20, 2024 | 153.76M |
| March 19, 2024 | 154.85M |
| March 18, 2024 | 138.99M |
| March 15, 2024 | 183.85M |
| March 14, 2024 | 170.44M |
| March 13, 2024 | 172.91M |
| March 12, 2024 | 171.54M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-37.14M
Minimum
Dec 17 2021
276.32M
Maximum
May 22 2019
61.82M
Average
53.80M
Median
Jul 16 2021
Enterprise Value Benchmarks
| T2 Biosystems Inc | 119.20M |
| INVO Bioscience Inc | 12.40M |
| Perspective Therapeutics Inc | 811.05M |
| Electromed Inc | 135.78M |
| Xtant Medical Holdings Inc | 120.67M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -31.58M |
| Total Expenses (Quarterly) | 14.33M |
| EPS Diluted (Quarterly) | -1.16 |
| Earnings Yield | -74.25% |
| Normalized Earnings Yield | -76.60 |